We’ve recently shared communications about updates to existing US Pharmacopeia Convention (USP) Chapters surrounding pharmaceutical compounding regulations as well as a new regulation for handling hazardous drugs in health care facilities. The new and updated rules were scheduled to go into effect Dec. 1.
In today’s increasingly complex health care environment, hospital leaders are challenged to improve patient outcomes, boost productivity, and increase provider and staff retention. Key to achieving these goals is having effective care teams that utilize each member to the fullest extent of their scope of practice and training.
As blockbuster biologics continue to come off patents, biosimilars are poised to play a crucial role in reshaping the treatment landscape for cancer and other chronic conditions. Besides producing equivalent outcomes to their biologic reference products, biosimilars are also expected to help lower the overall cost of health care.
This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.